Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs

作者: Klavs H Jørgensen , Axel K Hansen , Karsten Buschard , None

DOI: 10.1016/S0168-8227(00)00196-0

关键词: Semilente InsulinMedicineEndocrinologyAbsorption (skin)Diabetes mellitusPharmacokineticsInsulinHuman insulinInternal medicineDose–response relationshipPancreatic hormone

摘要: Human NPH U100 (100 IU/ml), given once daily, is often absorbed too fast to cover the basal insulin demand throughout 24 h. The aim of present study was examine whether absorption human suspensions would be delayed by increasing concentration from U500. In each experiment 10 IU corresponding Ul00 and U500 preparations, labelled with 125I-insulin, were injected subcutaneously contralaterally in neck a pig followed monitoring residual radioactivity over injection sites. time until 75, 50 25% (T(75%), T(50%) T(25%)) using compared 14 experiments: T(75%): 5.0+/-0.5 (mean+/-SEM) vs 3.8+/-0.3 h (P=0.007, paired t-test), T(50%): 12. 2+/-0.9 9.0+/-0.6 (P=0.003) T(25%). 24.2+/-1.2 17.9+/-1. 2 (P=0.001). values for semilente eight experiments were: 2.8+/-0.4 1.6+/-0.2 (P=0.02), 5.6+/-0.6 3.4+/-0.3 (P=0.01) T(25%): 10.9+/-1.1 7.2+/-0.7 (P=0.009). Thus, dose or pigs substantially changing appears more appropriate than daily therapy.

参考文章(14)
M. Berger, H. J. Cuppers, H. Hegner, V. Jorgens, P. Berchtold, Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations Diabetes Care. ,vol. 5, pp. 77- 91 ,(1982) , 10.2337/DIACARE.5.2.77
CHRISTIAN BINDER, Absorption of injected insulin. A clinical-pharmacological study. Pharmacology & Toxicology. ,vol. 27, pp. 1- 83 ,(2009) , 10.1111/J.1600-0773.1969.TB03069.X
A. H�binger, W. Weber, W. Jung, K. Wehmeyer, F.A. Gries, The pharmacokinetics of two different concentrations of short-acting insulin, intermediate-acting insulin, and an insulin mixture following subcutaneous injection Journal of Molecular Medicine. ,vol. 70, pp. 621- 626 ,(1992) , 10.1007/BF00184810
E A Chantelau, L Heinemann, A A Starke, Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin. Diabète & métabolisme. ,vol. 18, pp. 21- 24 ,(1992)
G Park, R H Rosskamp, Long-acting insulin analogs. Diabetes Care. ,vol. 22, pp. 109- 113 ,(1999)
M. Berger, P. A. Halban, L. Girardier, J. Seydoux, R. E. Offord, A. E. Renold, Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site. Diabetologia. ,vol. 17, pp. 97- 99 ,(1979) , 10.1007/BF01222209
G. B. Bolli, R. D. Di Marchi, G. D. Park, S. Pramming, V. A. Koivisto, Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia. ,vol. 42, pp. 1151- 1167 ,(1999) , 10.1007/S001250051286
K.H. J�rgensen, U.D. Larsen, Homogeneous mono-125I-insulins Diabetologia. ,vol. 19, pp. 546- 554 ,(1980) , 10.1007/BF00253183
J. Markussen, S. Havelund, P. Kurtzhals, A. S. Andersen, J. Halstr�m, E. Hasselager, U. D. Larsen, U. Ribel, L. Sch�ffer, K. Vad, I. Jonassen, Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia. ,vol. 39, pp. 281- 288 ,(1996) , 10.1007/BF00418343